Lupus & Connective Tissue Diseases
From the Journals
Patients With Stable Lupus May Be Safely Weaned Off MMF
Rates of significant disease reactivation were similar more than 1 year after randomization for patients assigned to mycophenolate mofetil (MMF)...
From the Journals
Comorbidities and Disease Type Weigh Heavily in Pregnancy Outcomes of Immune-Mediated Inflammatory Diseases
After controlling for other chronic conditions, certain immune-mediated inflammatory diseases were not associated with an increased risk for poor...
From the Journals
New Findings on Vitamin D, Omega-3 Supplements for Preventing Autoimmune Diseases
Omega-3 fatty acid supplements prevented autoimmune diseases for 2 years after cessation, but vitamin D’s effects tapered off, suggesting that...
From the Journals
Success with Sirolimus in Treating Skin Sarcoidosis Could Spur Studies in Other Organs
Vienna researchers reported that 7 of 10 patients treated with systemic sirolimus had noted improvements in skin lesions, which continued for up...
Latest News
Cutaneous lupus, dermatomyositis: Excitement growing around emerging therapies
Anticipation is growing for emerging therapies and their potential to provide relief to patients, said Anthony Fernandez, MD, PhD.
From the Journals
Tool Uses Genetics to Assist With Diagnosis of Early Inflammatory Arthritis
The tool may aid in accelerating accurate diagnosis and getting patients on the right treatments earlier.
Latest News
Study Identifies Cardiovascular Comorbidities Associated With Dermatomyositis
"Our findings are important both for prognosis and clinical care," the authors concluded.
Feature
Evidence Grows for SGLT2 Inhibitors in Rheumatology
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs...
From the Journals
Redosing Rituximab to Maintain ANCA Vasculitis Remission: When Is Best?
A single-center study found that using B-cell levels to determine when to infuse rituximab reduced relapses in patients antineutrophil cytoplasmic...
Feature
Sotatercept Endorsed for PAH by ICER
Drug’s novel mechanism of action raises hopes of disease-modifying activity, but long-term cost-effectiveness rests on improvement in functional...
Conference Coverage
CAR T-Cell Therapy: Cure for Systemic Autoimmune Diseases?
New research suggests that CAR T-cell therapy might prove to be a game-changing treatment for lupus and two other autoimmune diseases.